Laboratorios Casen Fleet Report issue

Contributed to NME For profit Phase 3 Phase 4
Founded: Madrid Spain (1947)
Status: Acquired by Recordati (2013)

Organization Overview

First Clinical Trial
2010
NCT01065857
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Laboratorios Casen-Fleet S.L.U.

Active Ingredients

Drugs in Phase 4 Trials (1)

soybean (1 trial)

Drugs in Phase 3 Trials (4)

citric acid (1 trial)

magnesium oxide (1 trial)

polyethylene glycol (1 trial)

sodium picosulfate (Preopik) (1 trial)

Indications

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 5